Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Amantadine in Treating Cognitive and Motor Impairments in Adolescents and Adults With Cerebral Palsy

NCT04273737 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT04273737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04273737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Amantadine in Treating Cognitive and Motor Impairments in Adolescents and Adults With Cerebral Palsy
Lead sponsor
Columbia University
Phase
Phase 4
Overall status
Terminated
Start date
February 28, 2020
Completion date
February 22, 2022
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy